ArticleSurgical case reports2026
Long-Term Survival after Repeat Resection and Multimodal Therapy for Primary Cardiac Angiosarcoma: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary cardiac angiosarcoma (PCA) is an exceptionally rare and aggressive malignant tumor characterized by a poor prognosis. Although complete surgical resection is the most effective treatment for survival, recurrence and metastasis occur frequently even after radical excision. CASE PRESENTATION: We report a rare case of PCA in a 40-year-old woman in whom long-term survival of 68 months was achieved through aggressive multimodal therapy. She underwent urgent complete resection of a right atrial tumor, followed by preoperative chemotherapy and repeat resection with tricuspid valve replacement for recurrent disease and pulmonary metastasis. Postoperative adjuvant chemotherapy resulted in disease-free survival of 41 months. The subsequent hepatic and pulmonary metastases were managed with chemotherapy and radiotherapy before the patient succumbed to multiple organ failure.
conclusionsIndividualized, aggressive, and multimodal treatment-including repeat surgical resection and sustained systemic therapy-can achieve durable disease control and prolonged survival in selected patients with PCA, a malignancy otherwise associated with extremely poor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.